Mainz Biomed MYNZ Stock
3.7 USD
{{ price }}
4.815866%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Diagnostics & Research
COUNTRY
United States
Exchange
NasdaqCM
Market Cap
11.24M USD
LOW - HIGH [24H]
3.57
-
4.43 USD
VOLUME [24H]
2.55M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-22.36 USD
Mainz Biomed Price Chart
Mainz Biomed MYNZ Financial and Trading Overview
| Mainz Biomed stock price | 3.7 USD |
| Previous Close | 4.98 USD |
| Open | 4.91 USD |
| Bid | 0 USD x 1300 |
| Ask | 0 USD x 1200 |
| Day's Range | 4.85 - 5 USD |
| 52 Week Range | 3.18 - 12.01 USD |
| Volume | 10.76K USD |
| Avg. Volume | 42.7K USD |
| Market Cap | 72.65M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -22.36 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11 USD |
MYNZ Valuation Measures
| Enterprise Value | 65.5M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.081761 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 106.93057 |
| Price/Book (mrq) | 7.5038285 |
| Enterprise Value/Revenue | 96.403 |
| Enterprise Value/EBITDA | -2.421 |
Trading Information
Mainz Biomed Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -45.46% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 12.01 USD |
| 52 Week Low | 3.18 USD |
| 50-Day Moving Average | 5.08 USD |
| 200-Day Moving Average | 6.73 USD |
MYNZ Share Statistics
| Avg. Volume (3 month) | 42.7K USD |
| Avg. Daily Volume (10-Days) | 22.45K USD |
| Shares Outstanding | 14.83M |
| Float | 10.83M |
| Short Ratio | 0.68 |
| % Held by Insiders | 24.48% |
| % Held by Institutions | 0.17% |
| Shares Short | 28.31K |
| Short % of Float | 0.22% |
| Short % of Shares Outstanding | 0.19% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -4027.78% |
| Gross Margin | 40.42% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -72.54% |
| Return on Equity (ttm) | -340.23% |
Income Statement
| Revenue (ttm) | 679.42K USD |
| Revenue Per Share (ttm) | 0.05 USD |
| Quarterly Revenue Growth (yoy) | 148.70% |
| Gross Profit (ttm) | N/A |
| EBITDA | -27058098 USD |
| Net Income Avi to Common (ttm) | -27284516 USD |
| Diluted EPS (ttm) | -1.86 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 10.86M USD |
| Total Cash Per Share (mrq) | 0.73 USD |
| Total Debt (mrq) | 3.71M USD |
| Total Debt/Equity (mrq) | 38.29 USD |
| Current Ratio (mrq) | 1.84 |
| Book Value Per Share (mrq) | 0.653 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -17670872 USD |
| Levered Free Cash Flow (ttm) | -5637179 USD |
Profile of Mainz Biomed
| Country | United States |
| State | N/A |
| City | Mainz |
| Address | Robert Koch Strasse 50 |
| ZIP | 55129 |
| Phone | 49 6131 554 2860 |
| Website | https://mainzbiomed.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 58 |
Mainz Biomed N.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics. It offers ColoAlert, a colorectal cancer screening stool-based deoxyribonucleic acid test; and PancAlert, a product candidate for a pancreatic cancer screening test. The company has a research collaboration with Microba Life Sciences to discover and develop novel therapeutics for major diseases. The company was founded in 2008 and is based in Mainz, Germany.
Q&A For Mainz Biomed Stock
What is a current MYNZ stock price?
Mainz Biomed MYNZ stock price today per share is 3.7 USD.
How to purchase Mainz Biomed stock?
You can buy MYNZ shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Mainz Biomed?
The stock symbol or ticker of Mainz Biomed is MYNZ.
Which industry does the Mainz Biomed company belong to?
The Mainz Biomed industry is Diagnostics & Research.
How many shares does Mainz Biomed have in circulation?
The max supply of Mainz Biomed shares is 3.04M.
What is Mainz Biomed Price to Earnings Ratio (PE Ratio)?
Mainz Biomed PE Ratio is now.
What was Mainz Biomed earnings per share over the trailing 12 months (TTM)?
Mainz Biomed EPS is -22.36 USD over the trailing 12 months.
Which sector does the Mainz Biomed company belong to?
The Mainz Biomed sector is Healthcare.
Mainz Biomed MYNZ included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17366.13 USD — |
-0.1
|
9.58B USD — | 17128.71 USD — | 17467.35 USD — | — - | 9.58B USD — |
| NASDAQ HealthCare IXHC | 931.02 USD — |
+0.81
|
— — | 921.75 USD — | 934.48 USD — | — - | — — |
- {{ link.label }} {{link}}